{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T07:22:00Z","timestamp":1793863320862,"version":"4.6.1"},"reference-count":113,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T00:00:00Z","timestamp":1659657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Rheumatoid arthritis (RA), an autoimmune disease, is characterized by the presence of symmetric polyarthritis predominantly of the small joints that leads to severe cartilage and bone destruction. Based on animal and human data, the pathophysiology of osteoporosis, a frequent comorbidity in conjunction with RA, was delineated. Autoimmune inflammatory processes, which lead to a systemic upregulation of inflammatory and osteoclastogenic cytokines, the production of autoantibodies, and Th cell senescence with a presumed disability to control the systemic immune system\u2019s and osteoclastogenic status, may play important roles in the pathophysiology of osteoporosis in RA. Consequently, osteoclast activity increases, osteoblast function decreases and bone metabolic and mechanical properties deteriorate. Although a number of disease-modifying drugs to treat joint inflammation are available, data on the ability of these drugs to prevent fragility fractures are limited. Thus, specific treatment of osteoporosis should be considered in patients with RA and an associated increased risk of fragility fractures.<\/jats:p>","DOI":"10.3390\/ijms23158740","type":"journal-article","created":{"date-parts":[[2022,8,7]],"date-time":"2022-08-07T22:51:46Z","timestamp":1659912706000},"page":"8740","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Mechanisms of Systemic Osteoporosis in Rheumatoid Arthritis"],"prefix":"10.3390","volume":"23","author":[{"given":"Peter","family":"Pietschmann","sequence":"first","affiliation":[{"name":"Institute of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9772-6665","authenticated-orcid":false,"given":"Maria","family":"Butylina","sequence":"additional","affiliation":[{"name":"Institute of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1128-7532","authenticated-orcid":false,"given":"Katharina","family":"Kerschan-Schindl","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine, Rehabilitation and Occupational Medicine, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8209-1804","authenticated-orcid":false,"given":"Wolfgang","family":"Sipos","sequence":"additional","affiliation":[{"name":"Clinical Department for Farm Animals, University of Veterinary Medicine Vienna, 1210 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/S0140-6736(17)31472-1","article-title":"Pathogenetic insights from the treatment of rheumatoid arthritis","volume":"389","author":"McInnes","year":"2017","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Omata, Y., Frech, M., Saito, T., Schett, G., Zaiss, M.M., and Tanaka, S. (2022). Inflammatory Arthritis and Bone Metabolism Regulated by Type 2 Innate and Adaptive Immunity. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031104"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy (2001). Osteoporosis Prevention, Diagnosis, and Therapy. JAMA, 285, 785\u2013795.","DOI":"10.1001\/jama.285.6.785"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"456","DOI":"10.5312\/wjo.v12.i7.456","article-title":"Optimization of transdisciplinary management of elderly with femur proximal extremity fracture: A patient-tailored plan from orthopaedics to rehabilitation","volume":"12","author":"Invernizzi","year":"2021","journal-title":"World J. Orthop."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s00198-018-4473-1","article-title":"Incidence of fractures among patients with rheumatoid arthritis: A systematic review and meta-analysis","volume":"29","author":"Jin","year":"2018","journal-title":"Osteoporos. Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s10067-021-06046-2","article-title":"Incidence and risk factors for vertebral fracture in rheumatoid arthritis: An update meta-analysis","volume":"41","author":"Liu","year":"2022","journal-title":"Clin. Rheumatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1007\/s00198-017-4170-5","article-title":"Skeletal complications of rheumatoid arthritis","volume":"28","author":"Heinlen","year":"2017","journal-title":"Osteoporos. Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/jbmr.2109","article-title":"Decreased Quantity and Quality of the Periarticular and Nonperiarticular Bone in Patients with Rheumatoid Arthritis: A Cross-Sectional HR-pQCT Study","volume":"29","author":"Kocijan","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41413-021-00149-x","article-title":"Skeletal endocrinology: Where evolutionary advantage meets disease","volume":"9","author":"Jaschke","year":"2021","journal-title":"Bone Res."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"F\u00f6ger-Samwald, U., Kerschan-Schindl, K., Butylina, M., and Pietschmann, P. (2022). Age Related Osteoporosis: Targeting Cellular Senescence. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23052701"},{"key":"ref_12","first-page":"1017","article-title":"Osteoporosis: Patho-physiology and therapeutic options","volume":"19","author":"Dovjak","year":"2020","journal-title":"EXCLI J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e10539","DOI":"10.1002\/jbm4.10539","article-title":"New Insights into Osteoclast Biology","volume":"5","author":"McDonald","year":"2021","journal-title":"JBMR Plus"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000431091","article-title":"Immunology of Osteoporosis: A Mini-Review","volume":"62","author":"Pietschmann","year":"2016","journal-title":"Gerontology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000342426","article-title":"Advances in Osteoimmunology: Pathophysiologic Concepts and Treatment Opportunities","volume":"160","author":"Rauner","year":"2013","journal-title":"Int. Arch. Allergy Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Gemmati, D., Varani, K., Bramanti, B., Piva, R., Bonaccorsi, G., Trentini, A., Manfrinato, M.C., Tisato, V., Car\u00e8, A., and Bellini, T. (2019). \u201cBridging the Gap\u201d Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21010296"},{"key":"ref_17","unstructured":"Pietschmann, P. (2012). RANKL Inhibition: Preclinical Data. Principles of Osteoimmunology: Molecular Mechanisms and Clinical Applications, Springer International Publishing."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s00774-017-0880-1","article-title":"Effect of prednisone treatment for 30 and 90 days on bone metabolism in collagen-induced arthritis (CIA) rats","volume":"36","author":"Zhang","year":"2018","journal-title":"J. Bone Miner. Metab."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1439-0442.2007.00968.x","article-title":"Minipigs and Potbellied Pigs as Pets in the Veterinary Practice\u2014A Retrospective Study","volume":"54","author":"Sipos","year":"2007","journal-title":"J. Vet. Med. Ser. A"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.2460\/javma.249.10.1156","article-title":"Clinical features and pathological joint changes in dogs with erosive immune-mediated polyarthritis: 13 cases (2004\u20132012)","volume":"249","author":"Shaughnessy","year":"2016","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1002\/art.10369","article-title":"Kinetics of bone protection by recombinant osteoprotegerin therapy in Lewis rats with adjuvant arthritis","volume":"46","author":"Campagnuolo","year":"2002","journal-title":"Arthritis Care Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"8222","DOI":"10.1073\/pnas.95.14.8222","article-title":"Interleukin 6 plays a key role in the development of antigen-induced arthritis","volume":"95","author":"Ohshima","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.4049\/jimmunol.131.6.2995","article-title":"Collagen-induced arthritis in rats: Anti-gen-specific suppression of arthritis and immunity by intravenously injected native type II collagen","volume":"131","author":"Cremer","year":"1983","journal-title":"J. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"R187","DOI":"10.1186\/ar2879","article-title":"RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: Comparison with anti-TNF\u03b1 or anti-IL-1 therapies","volume":"11","author":"Stolina","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s10875-008-9238-8","article-title":"The Evolving Systemic and Local Biomarker Milieu at Different Stages of Disease Progression in Rat Adjuvant-Induced Arthritis","volume":"29","author":"Stolina","year":"2009","journal-title":"J. Clin. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1080\/13547500802651911","article-title":"The evolving systemic and local biomarker milieu at different stages of disease progression in rat collagen-induced arthritis","volume":"13","author":"Stolina","year":"2009","journal-title":"Biomarkers"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"R158","DOI":"10.1186\/ar2838","article-title":"Regulation of pathogenic IL-17 responses in collagen-induced arthritis: Roles of endogenous interferon-gamma and IL-4","volume":"11","author":"Sarkar","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"6604","DOI":"10.4049\/jimmunol.169.11.6604","article-title":"The Role of Fc\u03b3R Signaling in the K\/B \u00d7 N Serum Transfer Model of Arthritis","volume":"169","author":"Corr","year":"2002","journal-title":"J. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1136\/annrheumdis-2013-203345","article-title":"Sclerostin inhibition reverses systemic, periarticular and local bone loss in arthritis","volume":"72","author":"Chen","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Moon, N., Effiong, L., Song, L., Gardner, T.R., and Soung, D.Y. (2019). Tart Cherry Prevents Bone Loss through Inhibition of RANKL in TNF-Overexpressing Mice. Nutrients, 11.","DOI":"10.3390\/nu11010063"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/art.10097","article-title":"Tumor necrosis factor \u03b1-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin","volume":"46","author":"Redlich","year":"2002","journal-title":"Arthritis Care Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s00774-015-0700-4","article-title":"Secondary osteoporosis in collagen-induced arthritis rats","volume":"34","author":"Wu","year":"2016","journal-title":"J. Bone Miner. Metab."},{"key":"ref_33","first-page":"731","article-title":"Combination therapy with dexamethasone and osteoprotegerin protects against arthritis-induced bone alterations in antigen-induced arthritis of the rat","volume":"59","author":"Oelzner","year":"2010","journal-title":"Agents Actions"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jphs.2021.10.006","article-title":"Peficitinib improves bone fragility by recovering bone turnover imbalance in arthritic mice","volume":"148","author":"Sugahara","year":"2022","journal-title":"J. Pharmacol. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1080\/03009742.2017.1416667","article-title":"Anti-interleukin-6 receptor antibody prevents loss of bone structure and bone strength in collagen-induced arthritis mice","volume":"47","author":"Yoshida","year":"2018","journal-title":"Scand. J. Rheumatol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Qiu, J., Lu, C., Zhang, L., Zhou, X., and Zou, H. (2022). Osteoporosis in patients with rheumatoid arthritis is associated with serum immune regulatory cellular factors. Clin. Rheumatol., 1\u20139.","DOI":"10.1007\/s10067-022-06212-0"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s40744-022-00452-x","article-title":"Abnormalities of Peripheral Lymphocyte Subsets in Rheumatoid Arthritis Patients Complicated with Osteoporosis","volume":"9","author":"Cheng","year":"2022","journal-title":"Rheumatol. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1006\/cyto.1998.0500","article-title":"Flow cytometrical determination of interleukin 1\u03b2, interleukin 6 and tumour necrosis factor \u03b1 in monocytes of rheumatoid arthritis patients; relation with parameters of osteoporosis","volume":"11","author":"Verbruggen","year":"1999","journal-title":"Cytokine"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00296-012-2375-7","article-title":"Relation of interleukin-6 in rheumatoid arthritis patients to systemic bone loss and structural bone damage","volume":"33","author":"Meguid","year":"2013","journal-title":"Rheumatol. Int."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s12016-013-8366-y","article-title":"Rheumatoid Arthritis Bone Fragility Is Associated with Upregulation of IL17 and DKK1 Gene Expression","volume":"47","author":"Rodrigues","year":"2014","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fimmu.2018.00095","article-title":"Senescent T-Cells Promote Bone Loss in Rheumatoid Arthritis","volume":"9","author":"Fessler","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1007\/s10067-007-0639-5","article-title":"Soluble receptor activator of NFkappa B-ligand and osteoprotegerin in rheumatoid arthritis\u2014Relationship with bone mineral density, disease activity and bone turnover","volume":"26","author":"Oelzner","year":"2007","journal-title":"Clin. Rheumatol."},{"key":"ref_43","first-page":"5567666","article-title":"Assessment of Serum sRANKL, sRANKL\/OPG Ratio, and Other Bone Turnover Markers with the Estimated 10-Year Risk of Major and Hip Osteoporotic Fractures in Rheumatoid Arthritis: A Cross-Sectional Study","volume":"2021","year":"2021","journal-title":"BioMed Res. Int."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1007\/s00296-011-2175-5","article-title":"Osteoprotegerin and RANKL in the pathogenesis of rheumatoid arthritis-induced osteoporosis","volume":"32","author":"Xu","year":"2011","journal-title":"Rheumatol. Int."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/apm.12467","article-title":"Elevated serum levels of Interleukin-37 are associated with inflammatory cytokines and disease activity in rheumatoid arthritis","volume":"123","author":"Yang","year":"2015","journal-title":"APMIS"},{"key":"ref_46","first-page":"275","article-title":"A Comparison of Demographics, Disease Activity, Disability, and Treatment Among Rheumatoid Arthritis Patients with and without Osteoporosis","volume":"13","author":"Abdulkhaliq","year":"2021","journal-title":"Open Access Rheumatol. Res. Rev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"151972","DOI":"10.1016\/j.semarthrit.2022.151972","article-title":"Low cumulative disease activity is associated with higher bone mineral density in a majority Latinx and Asian US rheumatoid arthritis cohort","volume":"53","author":"Wysham","year":"2022","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s00198-021-05824-7","article-title":"Vertebral fractures are increased in rheumatoid arthritis despite recent therapeutic advances: A case-control study","volume":"32","author":"Olmos","year":"2021","journal-title":"Osteoporos. Int."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10067-019-04787-9","article-title":"Prevalence and risk factors associated with vertebral osteoporotic fractures in patients with rheumatoid arthritis","volume":"39","author":"Tong","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13075-019-1956-1","article-title":"Distinct biomarkers for different bones in osteoporosis with rheumatoid arthritis","volume":"21","author":"Tomizawa","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jbspin.2012.08.004","article-title":"Common bone turnover markers in rheumatoid arthritis and ankylosing spondylitis: A literature review","volume":"80","author":"Coiffier","year":"2013","journal-title":"Jt. Bone Spine"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S8756-3282(98)00193-8","article-title":"Uncoupling of bone metabolism in rheumatoid arthritis patients with or without joint destruction: Assessment with serum type I collagen breakdown products","volume":"24","author":"Garnero","year":"1999","journal-title":"Bone"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.berh.2017.09.015","article-title":"The role of ACPAs in at-risk individuals: Early targeting of the bone and joints","volume":"31","author":"Schett","year":"2017","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"D\u2019Onofrio, B., Di Lernia, M., De Stefano, L., Bugatti, S., Montecucco, C., and Bogliolo, L. (2022). Personalized Therapeutic Strategies in the Management of Osteoporosis in Patients with Autoantibody-Positive Rheumatoid Arthritis. J. Clin. Med., 11.","DOI":"10.3390\/jcm11092341"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1136\/annrheumdis-2015-207871","article-title":"Enriching case selection for imminent RA: The use of anti-CCP antibodies in individuals with new non-specific musculoskeletal symptoms\u2014A cohort study","volume":"75","author":"Nam","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/annrheumdis-2012-202958","article-title":"Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies","volume":"73","author":"Kleyer","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/annrheumdis-2017-212404","article-title":"Biomechanical properties of bone are impaired in patients with ACPA-positive rheumatoid arthritis and associated with the occurrence of fractures","volume":"77","author":"Stemmler","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s13075-016-1116-9","article-title":"Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis","volume":"18","author":"Bugatti","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"613889","DOI":"10.3389\/fmed.2021.613889","article-title":"Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study","volume":"8","author":"Bruno","year":"2021","journal-title":"Front. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1136\/annrheumdis-2014-207219","article-title":"Autoantibodies to osteoprotegerin are associated with increased bone resorption in rheumatoid arthritis","volume":"74","author":"Hauser","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"908727","DOI":"10.3389\/fendo.2022.908727","article-title":"Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations from the Belgian Bone Club","volume":"13","author":"Laurent","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bone.2018.06.008","article-title":"The effect of glucocorticoids on bone mineral density in patients with rheumatoid arthritis: A systematic review and meta-analysis of randomized, controlled trials","volume":"114","author":"Blavnsfeldt","year":"2018","journal-title":"Bone"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00198-020-05360-w","article-title":"Effects of glucocorticoids on osteoporosis in rheumatoid arthritis: A systematic review and meta-analysis","volume":"31","author":"Wang","year":"2020","journal-title":"Osteoporos. Int."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Polito, A., Barnaba, L., Ciarapica, D., and Azzini, E. (2022). Osteosarcopenia: A Narrative Review on Clinical Studies. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23105591"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.2147\/IJGM.S349435","article-title":"Sarcopenia May Be a Risk Factor for Osteoporosis in Chinese Patients with Rheumatoid Arthritis","volume":"15","author":"Lian","year":"2022","journal-title":"Int. J. Gen. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00296-008-0576-x","article-title":"Significance of risk factors for osteoporosis is dependent on gender and menopause in rheumatoid arthritis","volume":"28","author":"Oelzner","year":"2008","journal-title":"Rheumatol. Int."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"891","DOI":"10.47391\/JPMA.3058","article-title":"Factors associated with low bone mineral density in postmenopausal women with rheumatoid arthritis","volume":"72","author":"Zahid","year":"2022","journal-title":"J. Pak. Med. Assoc."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e11122","DOI":"10.1097\/MD.0000000000011122","article-title":"Male patients with rheumatoid arthritis have an increased risk of osteoporosis","volume":"97","author":"Kweon","year":"2018","journal-title":"Medicine"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11657-021-00982-x","article-title":"Vitamin D deficiency is a risk factor for new fractures in Japanese postmenopausal women with rheumatoid arthritis: Results from the IORRA cohort study","volume":"16","author":"Nakayama","year":"2021","journal-title":"Arch. Osteoporos."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Hu, Z., Zhang, L., Lin, Z., Zhao, C., Xu, S., Lin, H., Zhang, J., Li, W., and Chu, Y. (2021). Prevalence and risk factors for bone loss in rheumatoid arthritis patients from South China: Modeled by three methods. BMC Musculoskelet. Disord., 22.","DOI":"10.1186\/s12891-021-04403-5"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1136\/annrheumdis-2021-221093","article-title":"Impact of sustaining SDAI remission for preventing incident of bone fragility fracture in patient with rheumatoid arthritis","volume":"81","author":"Yoshii","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1007\/s00296-020-04593-6","article-title":"Osteoporosis in patients with rheumatoid arthritis: Trends in the German National Database 2007\u20132017","volume":"40","author":"Lindner","year":"2020","journal-title":"Rheumatol. Int."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00198-016-3769-2","article-title":"Biologic therapies and bone loss in rheumatoid arthritis","volume":"28","author":"Zerbini","year":"2017","journal-title":"Osteoporos. Int."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"104354","DOI":"10.1016\/j.phrs.2019.104354","article-title":"Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis","volume":"147","author":"Orsolini","year":"2019","journal-title":"Pharmacol. Res."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Hauser, B., Raterman, H., Ralston, S.H., and Lems, W.F. (2022). The Effect of Anti-rheumatic Drugs on the Skeleton. Calcif. Tissue Res., 1\u201312.","DOI":"10.1007\/s00223-022-01001-y"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41584-022-00764-w","article-title":"Effects of targeted therapies on bone in rheumatic and musculoskeletal diseases","volume":"18","author":"Raterman","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1093\/rheumatology\/kez655","article-title":"The impact of long-term biologics\/target therapy on bone mineral density in rheumatoid arthritis: A propensity score-matched analysis","volume":"59","author":"Chen","year":"2020","journal-title":"Rheumatology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/rheumatology\/ket468","article-title":"The effect of tocilizumab on bone mineral density in patients with methotrexate-resistant active rheumatoid arthritis","volume":"53","author":"Kume","year":"2014","journal-title":"Rheumatology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jbspin.2014.10.015","article-title":"The effect of tocilizumab on bone mineral density, serum levels of Dickkopf-1 and bone remodeling markers in patients with rheumatoid arthritis","volume":"82","author":"Briot","year":"2015","journal-title":"Jt. Bone Spine"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Chen, Y.-M., Chen, H.-H., Huang, W.-N., Liao, T.-L., Chen, J.-P., Chao, W.-C., Lin, C.-T., Hung, W.-T., Hsieh, C.-W., and Hsieh, T.-Y. (2017). Tocilizumab potentially prevents bone loss in patients with anticitrullinated protein antibody-positive rheumatoid arthritis. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0188454"},{"key":"ref_81","first-page":"239","article-title":"Effect of Tocilizumab on Fatigue and Bone Mineral Density in Patients with Rheumatoid Arthritis","volume":"20","author":"Zisman","year":"2018","journal-title":"IMAJ"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00296-017-3922-z","article-title":"Abatacept might increase bone mineral density at femoral neck for patients with rheumatoid arthritis in clinical practice: AIRTIGHT study","volume":"38","author":"Tada","year":"2018","journal-title":"Rheumatol. Int."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"783030","DOI":"10.3389\/fimmu.2021.783030","article-title":"Different Effects of Biologics on Systemic Bone Loss Protection in Rheumatoid Arthritis: An Interim Analysis of a Three-Year Longitudinal Cohort Study","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Wheater, G., Elshahaly, M., Naraghi, K., Tuck, S.P., Datta, H.K., and Van Laar, J.M. (2018). Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, results from an exploratory, prospective study. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0201527"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"206","DOI":"10.5114\/reum.2021.108430","article-title":"Bone-sparing effects of rituximab and body composition analysis in a cohort of postmenopausal women affected by rheumatoid arthritis\u2014Retrospective study","volume":"59","author":"Falsetti","year":"2021","journal-title":"Reumatologia"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s00198-021-05871-0","article-title":"Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis","volume":"32","author":"Hamar","year":"2021","journal-title":"Osteoporos. Int."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1136\/ard.2009.112920","article-title":"Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates","volume":"69","author":"Dore","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"799575","DOI":"10.3389\/fimmu.2021.799575","article-title":"The Efficacy of Denosumab in Patients with Rheumatoid Arthritis: A Systematic Review and Pooled Analysis of Randomized or Matched Data","volume":"12","author":"Hu","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"rkab099","DOI":"10.1093\/rap\/rkab099","article-title":"Therapeutic efficacy of denosumab for rheumatoid arthritis: A systematic review and meta-analysis","volume":"5","author":"Yagita","year":"2021","journal-title":"Rheumatol. Adv. Pract."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2147\/TCRM.S156350","article-title":"Effects of denosumab on bone metabolism and bone mineral density with anti-TNF inhibitors, tocilizumab, or abatacept in osteoporosis with rheumatoid arthritis","volume":"14","author":"Suzuki","year":"2018","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e10393","DOI":"10.1002\/jbm4.10393","article-title":"The Association of Methotrexate, Sulfasalazine, and Hydroxychloroquine Use With Fracture in Postmenopausal Women With Rheumatoid Arthritis: Findings from the Women\u2019s Health Initiative","volume":"4","author":"Carbone","year":"2020","journal-title":"JBMR Plus"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00198-020-05664-x","article-title":"Methotrexate osteopathy: Five cases and systematic literature review","volume":"32","author":"Robin","year":"2021","journal-title":"Osteoporos. Int."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/annrheumdis-2019-215328","article-title":"Medications associated with fracture risk in patients with rheumatoid arthritis","volume":"78","author":"Ozen","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/jbmr.1489","article-title":"Effects of disease-modifying antirheumatic drugs on nonvertebral fracture risk in rheumatoid arthritis: A population-based cohort study","volume":"27","author":"Kim","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"ref_95","first-page":"3416","article-title":"Impact of biologic disease-modifying antirheumatic drugs on fracture risk in patients with rheumatoid arthritis: A systematic review and meta-analysis","volume":"25","author":"Shao","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/acr2.11292","article-title":"Comparative Risk of Nonvertebral Fractures Among Patients With Rheumatoid Arthritis Treated With Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs","volume":"3","author":"Pawar","year":"2021","journal-title":"ACR Open Rheumatol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"106278","DOI":"10.1016\/j.phrs.2022.106278","article-title":"Association between biologic therapy and fracture incidence in patients with selected rheumatic and autoimmune diseases: A systematic review and meta-analysis of randomized controlled trials","volume":"181","author":"Lv","year":"2022","journal-title":"Pharmacol. Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.amjmed.2022.01.017","article-title":"Biological Disease-Modifying Antirheumatic Drugs and Osteoporotic Fracture Risk in Patients with Rheumatoid Arthritis: A Danish Cohort Study","volume":"135","author":"Abtahi","year":"2022","journal-title":"Am. J. Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1007\/s00198-020-05488-9","article-title":"Comparative risk of osteoporotic fracture among patients with rheumatoid arthritis receiving TNF inhibitors versus other biologics: A cohort study","volume":"31","author":"Shin","year":"2020","journal-title":"Osteoporos. Int."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/mr\/roab043","article-title":"The real-world effectiveness of anti-RANKL antibody denosumab on the clinical fracture prevention in patients with rheumatoid arthritis: The ANSWER cohort study","volume":"32","author":"Murata","year":"2022","journal-title":"Mod. Rheumatol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00198-019-04966-z","article-title":"Increased risk of osteoporotic vertebral fracture in rheumatoid arthritis patients with new-onset cardiovascular diseases: A retrospective nationwide cohort study in Taiwan","volume":"30","author":"Hong","year":"2019","journal-title":"Osteoporos. Int."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/acr.21937","article-title":"Initiation of tumor necrosis factor \u03b1 antagonists and risk of fractures in patients with selected rheumatic and autoimmune diseases","volume":"65","author":"Kawai","year":"2012","journal-title":"Arthritis Care Res."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Timmen, M., Hidding, H., Wiesk\u00f6tter, B., Baum, W., Pap, T., Raschke, M.J., Schett, G., Zwerina, J., and Stange, R. (2014). Influence of antiTNF-alpha antibody treatment on fracture healing under chronic inflammation. BMC Musculoskelet. Disord., 15.","DOI":"10.1186\/1471-2474-15-184"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5387\/fms.57.11","article-title":"Effect of Methotrexate on Fracture Healing","volume":"57","author":"Satoh","year":"2011","journal-title":"Fukushima J. Med. Sci."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/annrheumdis-2019-216802","article-title":"Immunosuppression and the risk of readmission and mortality in patients with rheumatoid arthritis undergoing hip fracture, abdominopelvic and cardiac surgery","volume":"79","author":"George","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Gaber, T., Brinkman, A.C.K., Pienczikowski, J., Diesing, K., Damerau, A., Pfeiffenberger, M., Lang, A., Ohrndorf, S., Burmester, G.-R., and Buttgereit, F. (2020). Impact of Janus Kinase Inhibition with Tofacitinib on Fundamental Processes of Bone Healing. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21030865"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/acr.21987","article-title":"Risk Factors for Falls in Adults with Rheumatoid Arthritis: A Prospective Study","volume":"65","author":"Stanmore","year":"2013","journal-title":"Arthritis Care Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/jcsm.12189","article-title":"Changes in body composition and metabolic profile during interleukin 6 inhibition in rheumatoid arthritis","volume":"8","author":"Tournadre","year":"2017","journal-title":"J. Cachex Sarcopenia Muscle"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/14397595.2018.1510565","article-title":"Prevalence and factors associated with sarcopenia in patients with rheumatoid arthritis","volume":"29","author":"Torii","year":"2018","journal-title":"Mod. Rheumatol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"596007","DOI":"10.3389\/fmed.2020.596007","article-title":"The Effect of Vitamin D Supplementation on Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis","volume":"7","author":"Guan","year":"2020","journal-title":"Front. Med."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Nguyen, Y., Sigaux, J., Letarouilly, J.-G., Sanchez, P., Czernichow, S., Flipo, R.-M., Soubrier, M., Semerano, L., Seror, R., and Sellam, J. (2021). Efficacy of Oral Vitamin Supplementation in Inflammatory Rheumatic Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients, 13.","DOI":"10.3390\/nu13010107"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/art.20117","article-title":"Slowing of bone loss in patients with rheumatoid arthritis by long-term high-intensity exercise: Results of a randomized, controlled trial","volume":"50","author":"Munneke","year":"2004","journal-title":"Arthritis Care Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1055\/a-1561-3426","article-title":"Evolution and History of Osteoimmunology","volume":"30","author":"Pietschmann","year":"2021","journal-title":"Osteologie"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/15\/8740\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:04:51Z","timestamp":1760141091000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/15\/8740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,5]]},"references-count":113,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["ijms23158740"],"URL":"https:\/\/doi.org\/10.3390\/ijms23158740","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,5]]}}}